CTVA · Corteva Inc

NYSE Chemicals Mid Cap Clavix D
12.76−0.12  (−0.93%)

Price

Snapshot

50 fields · last close
Market Cap$8.59B
P/E8.52
Float668.1M
Beta0.70
Volatility17.4%
ExchangeNYSE
SectorChemicals
Cap tierMid cap
Macro sensitivityModerate
Clavix score41.8
Price12.76
Change−0.93%
Prev Close12.88
Open12.99
Day Low12.69
Day High13.17
Avg Vol44
Avg $ Vol$560.6M
52W High90.97
52W Low11.48
52W Pos1.6%
From High−85.97%
From Low+11.18%
Max DD 1Y−86.83%
Spread0.10%
LiquidityDeep
SMA 20−67.66%
SMA 50−80.32%
SMA 200−83.09%
RSI (14)9.4
Vol 30D528.9%
Vol 90D307.5%
1Y Range11–91
Daily bars536
Perf Week−2.72%
Perf Month−84.20%
Perf Quarter−85.16%
Perf Half Y−83.97%
Perf Year−79.20%
Perf YTD−81.17%
Prev Day−0.93%
ClavixD
Debt / Eq0.11
Curr Ratio1.43
Int Cover6.2×
FCF Margin19.6%
Rev Growth+2.9%
ProfitProfitable
LeverageLow
Sector rank17 / 17

What CTVA does

Corteva, Inc. operates in the agriculture business.

The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms.

It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability.

The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies.

This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides.

It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa.

The company was founded in 1802 and is headquartered in Indianapolis, Indiana.

Clavix risk grade

regraded every trading day
D41.8/100

CTVA grades D, 41.8 of 100. Steadiest on News Sentiment (67), most exposed on Price Stability (19, weak). 1 of the 4 weighted dimensions sit above the Chemicals median. Ranks 17 of 17 in Chemicals by Clavix score.

PriceMacroSectorNewsFinancial

How rough the ride is

CTVAChemicals median
Betavs the overall market · lower is steadier0.700.70
Volatilityannualized17.4%17.4%
Max drawdown, past yearworst peak-to-trough fall−86.8%—
Typical daily movemedian absolute daily change0.98%—
Days beyond ±3%of the last 252 sessions17 (7%)—

How its days are spread

Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.

52-week range

CTVA
12.88

The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.

Drawdown from the 1-year peak

CTVA

Percent below the running high over the last 12 months. Zero is a fresh high.

Market sensitivity

CTVAChemicals median
Beta to the markethow much it swings with the S&P 500 · lower is safer0.700.70
Macro sensitivityrate, dollar and credit exposure bucketModerateModerate 53% of 17

Where it sits on the macro scale

Low 6Moderate 9High 2Very High 0

Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Chemicals names sit in each bucket.

Where it ranks in its sector

Sector
Chemicals17 companies ranked
CTVA
#17 of 17

Rank by Clavix score within the sector. Right is the top of the sector.

Price performance

CTVA
1 week−2.7%
1 month−84.2%
Year to date−81.2%
1 year−79.2%

Context for the rank, not itself a risk measure.

Recent coverage, scored

CTVA
Articles scoredthe most recent scored coverage, up to 3030 since 18 Sep
Average score0 most bearish, 100 most bullish49
Bullish · bearisharticles above 60 · below 4011 · 11
Directionarticles whose tone is improving vs worsening11 ↑ 11 ↓

Where the article scores land

Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.

Balance sheet, against the sector

Debt / equityTotal debt vs shareholder equity · lower is stronger
0.11sector median 0.57 · 17 names
Current ratioShort-term assets vs liabilities · higher is stronger
1.43sector median 1.43 · 17 names
FCF marginFree cash flow as a share of revenue · higher is stronger
19.6%sector median 9.7% · 17 names
Interest coverageOperating income vs interest expense · higher is stronger
6.2×sector median 5.9× · 17 names

The shaded band is the middle half of the 17 Chemicals names Clavix covers; the tick is the sector median.

Growth

CTVA
Revenue growthyear over year+2.9%

Financial Health is shown but does not count toward the grade. Why

0–100, higher is safer. The tick on each bar is the Chemicals median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.

Recent news

most recent scored articles · the chip is the article’s score · click to open

A federal judge temporarily blocked Corteva and its subsidiary EIDP from making non-routine asset sales, paying dividends, or buying back their own shares, after 15 states and one foreign government sued to stop Corteva's planned separation from Vylor Inc. The next day the judge paused that order at Corteva's request so an appeals court can hear an emergency motion.

Source sec.gov Significance moderate Impact regulatory Risk worsening

Read the article →

Corteva has spun off its seed business into a new separate company called Vylor Inc., leaving Corteva focused on crop protection products and digital agriculture services. Legal questions have come up over how obligations related to PFAS chemicals (so-called 'forever chemicals' that don't break down easily in the environment) will be split between Corteva and Vylor.

Source yahoo.com Significance minor Impact regulatory Risk neutral

Read the article →

An analyst has issued a 'Buy' rating on Corteva, projecting about 3% annual revenue growth, a cumulative 150 basis point (1.5 percentage point) increase in EBITDA margin, and 6% annual EBITDA growth through fiscal 2029.

Source Seeking Alpha Significance minor Impact financial impact Risk improving

Read the article →

Zacks Research issued a written opinion cutting its rating on Corteva from 'hold' to 'strong sell' in a Tuesday report. No reason was given in the article.

Source marketbeat.com Significance minor Impact financial impact Risk worsening

Read the article →

Investors bought 5,408 call options on Corteva stock on Wednesday, which is about 532% more than the typical daily volume of 856 call options. A call option is a contract that pays off if the stock's price rises above a set level, so heavy call buying usually signals that traders expect the price to climb.

Source marketbeat.com Significance minor Impact other Risk improving

Read the article →

Nearest peers by size

Chemicals
TickerCompanyGradeMkt capP/EBeta
ESIElement Solutions IncC+$8.54B47.821.30Compare
NEUNewMarket CorpB+$8.06B18.590.59Compare
SOLSSolstice Advanced Materials IncC+$9.41B44.830.21Compare
ALBAlbemarle CorpB-$11.27B50.261.38Compare
MOSMosaic CoB$5.98B11.060.86Compare
DDDupont De Nemours IncB$17.62B320.301.08Compare
CFCF Industries Holdings IncB+$18.29B8.710.56Compare
LYBLyondellBasell Industries NVB+$20.68B—0.36Compare

You just read one holding. Clavix reads the whole portfolio.

Every position you own, graded on the same five dimensions, with an alert when a grade moves. 1 month free on iPhone.